<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="83818">
  <stage>Registered</stage>
  <submitdate>16/04/2009</submitdate>
  <approvaldate>5/05/2009</approvaldate>
  <actrnumber>ACTRN12609000225213</actrnumber>
  <trial_identification>
    <studytitle>Estimation of a clot end-product called D-Dimer in different stages of pregnancy with establishment of a normal value for Tasmanian women.</studytitle>
    <scientifictitle>Estimation of D-Dimer in different stages of pregnancy with establishment of a reference range for Tasmanian women and investigation of a possible association with high risk pregnancy, disseminated intravascular coagulation (DIC), venous thromboembolic (VTE) disease and pregnancy loss.</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>nil known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>The association of D-Dimer levels with normal pregnancy and also high risk pregnancy, DIC, venous thromboembolic (VTE) and pregnancy loss.</healthcondition>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Normal pregnancy</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Observational study of D-Dimer levels in pregnancy and the possible association between D-Dimer levels and high risk pregnancy, disseminated intravascular coagulation, venous thomboembolism and pregnancy loss.  Observation to continue into the postpartum period until D-Dimer levels return to normal, non-pregnant levels.</interventions>
    <comparator>Not applicable as it is an observational study.</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>The statistical establishment of normal D-dimer levels in each trimester of pregnancy supported by haematological evaluation and well-being questionnaires.</outcome>
      <timepoint>Blood sample once per trimester of pregnancy.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>The seconday outcome will be to determine and evaluate the optimum diagnostic thresholds for D-Dimer levels as predictors of adverse pregnancy outcomes.  This will be done by monitoring D-Dimer levels whilst assessing patients for indicators of adverse pregnancy outcomes.  This will be acheived through the use of haematological assessment, the use of well-being questionnaires and hospital records of patients' admission for treatment of pathology during pregnancy.</outcome>
      <timepoint>Blood sampled once per trimester in pregnancy, with monthly blood samples from women whose D-Dimer level was higher than the estimated average normal range inpregnancy.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Pregnant women 18 years old and above.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>Age less than 18 years.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs>Screening</purposeobs>
    <duration>Longitudinal</duration>
    <selection>Defined population</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>22/03/2007</anticipatedstartdate>
    <actualstartdate>22/03/2007</actualstartdate>
    <anticipatedenddate />
    <actualenddate>31/01/2009</actualenddate>
    <samplesize>700</samplesize>
    <actualsamplesize>632</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>TAS</recruitmentstate>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Assoc Professor Alhossain Khalafallah</primarysponsorname>
    <primarysponsoraddress>C/- Pathology Department
Launceston General Hospital
Charles St, Launceston 
Tasmania 7250</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Clifford Craig Medical Research Trust</fundingname>
      <fundingaddress>Level 5 
Launceston General Hospital
Charles St Launceston 
Tasmania 7250</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Launceston General Hospital</fundingname>
      <fundingaddress>Charles Street, Launceston, TAS 7250</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This study aims to find out the normal level of D-Dimer during different stages of pregnancy and to assess whether D-Dimer levels are associated with various abnormal outcomes of pregnancy for women in Tasmania.</summary>
    <trialwebsite />
    <publication>Khalafallah AA, Morse M, Al-Barzan AM, Adams M, Dennis A, Bates G, Robertson I, Seaton D, Brain T. D-Dimer levels at different stages of pregnancy in Australian women: a single centre study using two different immunoturbidimetric assays. Thromb Res. 2012 Sep;130(3):e171-7. doi: 10.1016/j.thromres.2012.05.022. Epub 2012 Jun 15.

http://www.ncbi.nlm.nih.gov/pubmed/22704076
</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Human Research Ethics Committee (Tasmania) Network</ethicname>
      <ethicaddress>Office of Research Services
University of Tasmania
Private Bag 1
Hobart Tasmania, 7001</ethicaddress>
      <ethicapprovaldate>20/09/2006</ethicapprovaldate>
      <hrec>H0008950</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Prof</title>
      <name>Assoc Professor Alhossain Khalafallah</name>
      <address>C/- Pathology Department
Launceston General Hospital
Charles St, Launceston 
Tasmania 7250</address>
      <phone>+61 417 324 623</phone>
      <fax>+61 363487695</fax>
      <email>khalafallah@dhhs.tas.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Assoc. Professor Alhossain Khalafallah</name>
      <address>C/- Pathology Department 
Launceston General Hospital
Charles St, Launceston 
Tasmania 7250</address>
      <phone>+61 417 324 623</phone>
      <fax>+61 363487695</fax>
      <email>khalafallah@dhhs.tas.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Alhossain Khalafallah</name>
      <address>C/- Haematology Research Unit
Launceston General Hospital,
Charles St, Launceston 
Tasmania 7250</address>
      <phone>+61 363487486</phone>
      <fax>+61 363487695</fax>
      <email>joanne.bates@dhhs.tas.gov.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Alhossain Khalafallah </name>
      <address>Pathology Department Launceston General Hospital Charles St, Launceston Tasmania 7250</address>
      <phone>+61367776777</phone>
      <fax />
      <email>khalafallah@dhhs.tas.gov.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>